It has since been approved by the FDA in 2021 as a long-term weight management injectable that can be used in patients with a BMI in the 95th percentile for their corresponding age and gender
The research was conducted at Ktahya Health Sciences University in Trkiye, including the School of Medicine, the Department of Medical Pharmacology, the Department of Histology and Embryology, the Department of Biochemistry, and the Faculty of Engineering and Natural Sciences, Department of Computer Engineering
Patients should expect some fluctuations in their symptoms during this time, but with proper treatment, these should subside over time
A licensed provider should review the patients symptoms, medications, medical history, treatment goals, and response before recommending or adjusting a protocol
Cantin, H